Research Paper Volume 14, Issue 17 pp 7038—7051
The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer
Figure 1. The downgulated co-DEGs in the drug-metabolism related geneset and two GC datasets. The Venn plot depicting three downregulated drug-metabolism related genes (ALDH6A1, ALDH3A1 and SLC7A8) could be correlated with the GC patients’ progression.